Cyrcadia Health‘s iTBra contains patches that detect circadian temperature changes within breast cells. The data is sent to a lab via smartphone, and analyzed with Nanyang Technical University developed algorithms. Abnormal temperature and cellular signaling patterns are immediately sent to one’s doctor.

The technology detects normal circadian cellular baselines, as well as abnormal patterns associated with cancer. The company claims that the device’s accuracy is similar to that of mammography, and particularly benefits those with dense breast tissue.

A clinical trial will soon begin, studying women wearing the device for different lengths of time.

Wearable Tech + Digital Health NYC 2015 – June 30 @ New York Academy of Sciences